News
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women, AP said. Both groups saw health improvements in blood pressure, blood sugar and blood fat levels, too.
5hon MSN
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback